Literature DB >> 17889958

A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity.

Mari Inoue1, Hiroshi Takata, Yukio Ikeda, Tadashi Suehiro, Shojiro Inada, Fumiaki Osaki, Kaoru Arii, Yoshitaka Kumon, Kozo Hashimoto.   

Abstract

alpha2-Heremans Schmid glycoprotein (AHSG), also designated fetuin-A, is an abundant plasma protein that is expressed in hepatocytes. AHSG/fetuin-A has diverse biological functions including regulation of calcium homeostasis and inhibition of insulin receptor tyrosine kinase activity. The aim of this study was to detect single nucleotide polymorphisms (SNPs) of the AHSG gene that can be involved in regulation of AHSG/fetuin-A expression. By a cycle sequencing method, two common SNPs in the promoter region of AHSG gene, -799A/T (rs2248690, dbSNP ID) and -425G/T (rs2077119), were identified. A reporter gene assay using HepG2 cells showed that the -799A allele had significantly higher promoter activity compared with the -799T allele. The overexpression of c-Fos/c-Jun significantly repressed transcriptional activity and a gel shift assay showed that the -799T DNA fragment had a greater affinity for transcription factor AP-1 than the -799A. In 40 unrelated healthy subjects, serum AHSG/fetuin-A levels increased with the following order of genotypes: -799TT<-799AT<-799AA (mean+/-S.E.M.; 222.1+/-11.0, 291.8+/-8.1, and 349.0+/-13.0 microg/ml, respectively, P<0.001). In conclusion, SNP rs2248690 in the promoter region of the AHSG gene affects the AHSG gene transcription, possibly by producing different association with AP-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889958     DOI: 10.1016/j.diabres.2007.08.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL.

Authors:  Kelly Vallance; Wei Liu; Belinda N Mandrell; John C Panetta; Jami S Gattuso; Marilyn Hockenberry; Sue Zupanec; Lei Yang; Jie Yang; Pamela S Hinds
Journal:  Eur J Cancer       Date:  2010-04-17       Impact factor: 9.162

Review 2.  The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.

Authors:  F Roshanzamir; M Miraghajani; M H Rouhani; M Mansourian; R Ghiasvand; S M Safavi
Journal:  J Endocrinol Invest       Date:  2017-06-22       Impact factor: 4.256

3.  Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies.

Authors:  Lars E Laugsand; Joachim H Ix; Traci M Bartz; Luc Djousse; Jorge R Kizer; Russell P Tracy; Abbas Dehghan; Kathryn Rexrode; Oscar L Lopez; Eric B Rimm; David S Siscovick; Christopher J O'Donnell; Anne Newman; Kenneth J Mukamal; Majken K Jensen
Journal:  Atherosclerosis       Date:  2015-09-05       Impact factor: 5.162

4.  Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Authors:  Majken K Jensen; Richard A Jensen; Kenneth J Mukamal; Xiuqing Guo; Jie Yao; Qi Sun; Marilyn Cornelis; Yongmei Liu; Ming-Huei Chen; Jorge R Kizer; Luc Djoussé; David S Siscovick; Bruce M Psaty; Joseph M Zmuda; Jerome I Rotter; Melissa Garcia; Tamara Harris; Ida Chen; Mark O Goodarzi; Michael A Nalls; Margaux Keller; Alice M Arnold; Anne B Newman; Ron C Hoogeveen; Kathryn M Rexrode; Eric B Rimm; Frank B Hu; Vasan S Ramachandran; Ronit Katz; James S Pankow; Joachim H Ix
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 5.121

5.  Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection.

Authors:  Xiaohui Zhu; Yan Wang; Hongxing Zhang; Xuan Liu; Ting Chen; Ruifu Yang; Yuling Shi; Wuchun Cao; Ping Li; Qingjun Ma; Yun Zhai; Fuchu He; Gangqiao Zhou; Cheng Cao
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study.

Authors:  Majken K Jensen; Traci M Bartz; Luc Djoussé; Jorge R Kizer; Susan J Zieman; Eric B Rimm; David S Siscovick; Bruce M Psaty; Joachim H Ix; Kenneth J Mukamal
Journal:  Diabetes Care       Date:  2013-06-25       Impact factor: 19.112

7.  Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts.

Authors:  György Temesszentandrási; Krisztián Vörös; Bernadett Márkus; Zoltán Böröcz; Edit Kaszás; Zoltán Prohászka; András Falus; Károly Cseh; László Kalabay
Journal:  Med Sci Monit       Date:  2016-08-04

8.  Allelic Imbalance of mRNA Associated with α2-HS Glycoprotein (Fetuin-A) Polymorphism.

Authors:  Yoshihiko Inaoka; Motoki Osawa; Nahoko Mukasa; Keiko Miyashita; Fumiko Satoh; Yu Kakimoto
Journal:  Dis Markers       Date:  2015-10-15       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.